Feline Diabetes Mellitus: Remission Induction and Monitoring

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Remission in feline diabetes mellitus is defined as sustained normoglycaemia without insulin for at least 2 to 4 weeks, characterized by normal clinical signs and fasting glucose below 180 mg/dL (10.0 mmol/L).
• Insulin weaning is triggered by a blood glucose nadir below 90 mg/dL (5.0 mmol/L) or persistent clinical hypoglycemia, with dose reductions of 25% to 50% every 5 to 7 days, guided by glucose curves or serial readings.
• A low-carbohydrate, high-protein diet (approximately 12-15% of metabolisable energy from carbohydrate) is a cornerstone for remission induction, alongside gradual weight loss of 0.5-1% per week in overweight cats after glycaemic stabilization.
• Early and intensive glycaemic control with long-acting insulin preparations is critical, as chronic hyperglycemia exacerbates beta-cell dysfunction and insulin resistance, hindering remission potential.
• Post-remission surveillance is essential, involving periodic glucose measurements for months to detect relapses, which can be precipitated by obesity, concurrent illness (e.g., acromegaly), or corticosteroid administration.
• Common errors in remission management include failing to adjust insulin doses as glucose normalizes, misinterpreting single glucose readings, and abruptly stopping insulin without confirmed euglycaemia, all of which can lead to hypoglycemia or relapse.

This article provides a clinical framework for inducing and confirming diabetic remission in cats, with emphasis on insulin weaning protocols, dietary strategy, and monitoring schedules. It is written for practicing veterinarians managing diabetic cats in first-opinion and referral settings. The content assumes familiarity with diabetes diagnosis and routine insulin dose adjustment, and it focuses on uncomplicated diabetic cats. Complicated presentations, including ketoacidosis, acromegaly, and concurrent disease that alters insulin sensitivity, are addressed only where they directly affect remission decisions.

The central clinical question is practical: once a diabetic cat begins insulin therapy, how does the clinician recognize that remission is possible, when and how should insulin be reduced, and what monitoring distinguishes true remission from transient euglycaemia? A secondary question concerns the role of diet and body weight in making remission more likely. The evidence base for feline diabetic remission is moderate to poor in quality, with frequent bias from small sample sizes, inconsistent remission definitions, and poor control of confounding factors, as documented in a systematic review of remission studies. Clinicians should therefore apply published remission rates with caution and rely on individual patient response.

At a Glance

Pathophysiology of Remission

Feline diabetes mellitus is most commonly type 2 in nature, characterized by insulin resistance and progressive beta-cell dysfunction. At diagnosis, most cats are insulin-dependent in the sense that exogenous insulin is required to control hyperglycemia, but this does not imply permanent beta-cell failure. The beta-cell dysfunction in type 2 diabetes is partly functional and potentially reversible, particularly when glucose toxicity is relieved. Chronic hyperglycemia itself impairs insulin secretion and worsens insulin resistance, creating a self-perpetuating cycle. Early glycaemic control with exogenous insulin breaks this cycle and allows partial recovery of endogenous insulin secretion, which is the physiological basis for remission.

Obesity amplifies insulin resistance through multiple mechanisms, and each excess kilogram of body weight is associated with a substantial decline in insulin sensitivity. Weight loss therefore improves the balance between insulin demand and beta-cell capacity, which is why body condition management is integral to remission induction. The domestic cat's evolutionary adaptation to low carbohydrate prey has led to speculation that high carbohydrate diets contribute to obesity and diabetes, and remission rates appear higher in cats fed low carbohydrate diets. The precise nutrient profile to which feline metabolism is adapted remains incompletely defined, but the practical implication for diabetic cats is consistent across published guidance.

Defining Remission

A uniform definition of remission is essential for clinical decision-making and for interpreting the literature. The systematic review of feline diabetic remission identified inconsistent remission criteria as a major source of bias across studies. For clinical purposes, remission is best defined as sustained normoglycaemia without exogenous insulin for a defined period, typically 2 to 4 weeks. The cat should be clinically well, with no polyuria, polydipsia, or weight loss attributable to diabetes, and blood glucose concentrations should remain within an acceptable range on a standard diet.

Partial remission is a separate category. A cat that requires a reduced insulin dose but still needs some exogenous insulin has not achieved remission, although it may be on the path toward it. The distinction matters because continued insulin therapy at a reduced dose may promote further beta-cell recovery, whereas premature cessation of insulin in a cat that still needs it risks recurrence of hyperglycemia and glucose toxicity. The goal of treatment is to maximize the chance of remission while minimizing the risk of hypoglycemia, a balance that requires structured weaning instead of abrupt discontinuation.

Insulin Therapy and Early Glycaemic Control

The choice of insulin and the intensity of early glycaemic control influence remission likelihood. Long-acting insulin preparations are preferred as initial choices in diabetic cats. The rationale is that a stable basal insulin profile more closely mimics physiologic insulin secretion and avoids the wide glucose fluctuations seen with shorter-acting preparations. Twice daily administration of a long-acting insulin is commonly recommended to achieve consistent glycaemic control.

Early and effective glycaemic control appears to be the single most important modifiable factor for remission. The concept is that prompt relief of glucose toxicity maximizes the chance of beta-cell recovery before irreversible damage occurs. Delays in achieving glycaemic control, whether from underdosing, infrequent monitoring, or poor owner compliance, reduce the likelihood of remission. This principle underlies the recommendation to initiate insulin therapy immediately at diagnosis and to monitor intensively during the first weeks of treatment.

Insulin resistance should be suspected when a cat requires persistently high insulin doses without adequate glycaemic response. Underlying causes include acromegaly, hyperadrenocorticism, and concurrent disease. In cats with acromegaly, radiotherapy can improve diabetic control and, in some cases, allow remission of diabetes, although the response is variable and the evidence comes from small case series. Clinicians should investigate insulin resistance before concluding that remission is unattainable, because treatment of the underlying condition may restore insulin sensitivity.

Monitoring During Remission Induction

The first 4 to 6 weeks after diagnosis set the trajectory for remission. During this period, the clinician's task is to titrate insulin against serial glucose measurements while the pancreas recovers. Twice-daily administration of a long-acting insulin such as glargine, combined with a low-carbohydrate diet, is the approach most consistently associated with remission in the veterinary literature Gostelow R, Forcada Y, Graves T, Church D, Niessen S. Systematic review of feline diabetic remission: separating fact from opinion. The evidence base is moderate to poor in quality, so protocols must remain flexible and responsive to individual patient data.

Glucose Curve Interpretation

A glucose curve should be performed 5 to 7 days after starting insulin and again after each dose adjustment. The curve consists of blood glucose measurements taken every 2 hours over a 12 hour period, beginning immediately before the morning insulin injection. For cats on twice-daily insulin, the curve should extend through the second injection to capture the full dosing interval.

Interpret the curve against three parameters:

The Somogyi phenomenon, rebound hyperglycemia after an undetected hypoglycemic episode, should be suspected when the nadir is low and the subsequent rise is steep. If the nadir falls below 90 mg/dL, reduce the dose by 25% regardless of the overall curve shape. If the nadir is above 180 mg/dL and the excursion is narrow, increase the dose by 0.5 to 1 unit per injection. Dose adjustments should be made no more frequently than every 5 to 7 days to allow steady-state effects.

Home Monitoring and Owner Documentation

Home glucose monitoring with a portable blood glucose meter designed for cats reduces the number of clinic visits and provides data from unstressed animals. Stress hyperglycemia in the hospital setting can produce falsely elevated readings that mimic insulin resistance Gottlieb S, Rand J. Managing feline diabetes: current perspectives. Owners should be trained to sample from the ear margin or paw pad using a lancet device, and they should record the following in a standardized log:

• Date and time of each glucose measurement
• Insulin dose and injection site
• Food intake and amount consumed
• Body weight measured weekly
• Clinical signs including thirst, urination frequency, appetite, and activity level

The log is reviewed at each recheck appointment. Trends matter more than individual readings. A cat that shows progressive decline in insulin requirement over consecutive curves is entering the remission window even if the current dose remains unchanged.

Dietary Strategy for Remission

Dietary modification is the second pillar of remission induction. The domestic cat retains the metabolic adaptations of an obligate carnivore, and its carbohydrate metabolism reflects this evolutionary heritage Verbrugghe A, Hesta M. Cats and Carbohydrates: The Carnivore Fantasy?. Low-carbohydrate, high-protein diets reduce postprandial glucose excursions and lower the insulin requirement needed to maintain euglycaemia.

Diet Selection Criteria

Choose a diet with less than 12% of metabolisable energy from carbohydrate and more than 40% from protein Clark M, Hoenig M. Feline comorbidities: Pathophysiology and management of the obese diabetic cat. Canned formulations are preferred over dry because they typically contain fewer carbohydrates and higher moisture content. The transition should be gradual over 7 to 10 days to avoid anorexia and gastrointestinal upset.

For obese cats, caloric restriction must be deferred until glycaemic control is established. Many diabetic cats have lost muscle mass by the time of diagnosis, and further restriction before insulin is stabilized can precipitate hepatic lipidosis. Once the cat is eating consistently and glucose curves are acceptable, begin weight reduction at 0.5% to 1% of body weight per week, feeding 80% of the resting energy requirement for ideal weight Clark M, Hoenig M. Feline comorbidities: Pathophysiology and management of the obese diabetic cat. Each excess kilogram of body weight reduces insulin sensitivity by approximately 30%, so weight loss directly improves the likelihood of remission.

Feeding Timing Relative to Insulin

Administer insulin immediately after the cat has eaten half of its meal. This ensures that the cat has consumed food before receiving an agent that can cause hypoglycemia. If the cat eats less than half the meal, give a reduced insulin dose or withhold the injection and monitor glucose. The same rule applies at every injection. Consistency in meal timing and portion size is more important than the specific diet chosen.

Insulin Weaning Protocol

Remission is defined as sustained normoglycaemia without exogenous insulin for at least 2 to 4 weeks Gostelow R, Forcada Y, Graves T, Church D, Niessen S. Systematic review of feline diabetic remission: separating fact from opinion. The weaning process begins when glucose nadirs fall below the target range on a consistent basis or when the cat experiences hypoglycemic episodes at the current dose.

Stepwise Dose Reduction

Reduce the insulin dose by 25% to 50% when any of the following occur:

• Nadir glucose below 90 mg/dL (5.0 mmol/L) on two consecutive curves
• Clinical signs of hypoglycemia, including lethargy, ataxia, or seizures
• Glucose measurements consistently below 200 mg/dL (11.1 mmol/L) throughout the curve

After each reduction, repeat the glucose curve in 5 to 7 days. If the cat remains euglycaemic on a dose of 0.5 units per injection or less, consider alternate-day dosing for 1 week before discontinuing entirely. Some protocols omit the alternate-day step and stop insulin directly when the dose reaches 0.5 units twice daily with nadirs above 90 mg/dL.

Criteria for Stopping Insulin

Stop insulin when the cat has maintained glucose concentrations between 90 and 200 mg/dL (5.0 to 11.1 mmol/L) for a full 12 hour curve on a dose of 0.5 units or less per injection. After the final injection, monitor glucose twice daily for 3 days, then daily for 1 week. If glucose remains below 200 mg/dL without insulin, remission is confirmed. The cat should continue the low-carbohydrate diet indefinitely, as dietary change alone may maintain remission in some cats Rand JS, Marshall RD. Diabetes mellitus in cats.

Remission Monitoring Schedule

Once remission is confirmed, the monitoring intensity decreases but does not cease. Relapse rates are substantial, and early detection of recurrent hyperglycemia allows prompt reinstitution of insulin therapy before complications develop.

Post-Remission Surveillance

Fructosamine reflects average glucose over the preceding 2 to 3 weeks and is useful when stress hyperglycemia confounds single measurements. A fructosamine value within the reference interval supports remission, while a rising trend signals impending relapse. Owners should be instructed to monitor for polydipsia, polyuria, and weight loss between scheduled visits and to report these signs immediately.

Factors That Precipitate Relapse

Obesity remains the most important modifiable risk factor. Weight gain after remission should trigger dietary intervention and increased monitoring. Concurrent illness, particularly acromegaly, pancreatitis, and hyperthyroidism, can induce insulin resistance and recurrent hyperglycemia. In cats with acromegaly treated with radiotherapy, diabetic control may improve substantially, and some cats enter remission after treatment Dunning MD, Lowrie CS, Bexfield NH, Dobson JM, Herrtage ME. Exogenous insulin treatment after hypofractionated radiotherapy in cats with diabetes mellitus and acromegaly. However, the response is variable, and insulin requirements may take months to stabilize.

Glucocorticoid administration, whether oral, topical, or injectable, is a common iatrogenic cause of relapse. Any cat in remission that requires corticosteroids should be monitored closely for hyperglycemia, and the lowest effective dose should be used.

Recognized Complications and Early Detection

Hypoglycemia remains the most immediate risk during remission induction. It occurs when insulin requirements fall faster than the dose adjustment schedule anticipates, or when food intake drops without corresponding insulin reduction. Early detection depends on owner recognition of lethargy, ataxia, vocalisation, or apparent hunger, but subclinical episodes are common. Serial glucose curves performed at each dose reduction step will identify nadirs below the target range before clinical signs develop. A nadir below 3.3 mmol/L (60 mg/dL) at any point warrants a dose reduction regardless of clinical appearance.

Somogyi phenomenon, rebound hyperglycemia following an undetected hypoglycemic episode, presents as persistent or worsening hyperglycemia on a curve. The discriminating feature is a low nadir earlier in the curve followed by rising values. Clinicians who respond to the hyperglycemia by increasing insulin dose worsen the cycle. A curve that shows both a nadir and subsequent elevation should be interpreted as hypoglycemia with rebound, not inadequate dosing.

Transient remission followed by relapse within weeks is a recognized pattern. It typically reflects incomplete beta-cell recovery instead of treatment failure. Cats that relapse after a brief euglycaemic period often respond to re-institution of insulin at the previous dose, but the underlying insulin resistance should be reassessed. Weight gain, intercurrent disease, and glucocorticoid exposure are common precipitants.

Common Errors in Remission Management

The most frequent error is continuing a fixed insulin dose after glucose concentrations have fallen into the low-normal range. Remission induction is dynamic, and dose reductions should be anticipated at every recheck. A second error is interpreting a single blood glucose measurement as representative of the full 12 hour cycle. A single value cannot distinguish adequate control from Somogyi rebound or from a curve that is acceptable at one time point but unacceptable at others.

Withholding insulin entirely when a cat is eating poorly, without measuring glucose, risks prolonged hyperglycemia and ketosis. The correct response is to measure glucose and adjust the dose proportionally, not to omit it reflexively. Conversely, some clinicians continue insulin in a cat that has been euglycaemic for days because the owner reports normal behavior. Remission criteria, not owner impression, should drive the decision to stop insulin.

Dietary errors include switching to a low-carbohydrate diet without adjusting insulin, which can precipitate hypoglycemia within days, and failing to maintain dietary consistency during the weaning period. The evidence linking low-carbohydrate diets to higher remission rates is drawn from a systematic review that rated the overall evidence base as moderate to poor, so dietary change should be implemented with correspondingly careful monitoring Gostelow et al., systematic review of feline diabetic remission.

Troubleshooting Guide

Evidence Limitations and Divergent Expert Opinion

The evidence base for remission protocols is constrained by heterogeneous study design. The systematic review by Gostelow and colleagues identified frequent failures to define diabetes and remission criteria, small sample sizes, and poor control of confounding variables across the 22 studies assessed systematic review of feline diabetic remission. Consequently, remission rates quoted in the literature vary widely, and direct comparisons between insulin types or dietary protocols should be made cautiously.

Expert opinion diverges on the speed of insulin weaning. Some authorities advocate rapid reduction once glucose falls below 10 mmol/L (180 mg/dL), while others prefer a slower taper over several weeks to reduce relapse risk. Neither approach is supported by high-quality comparative data. Similarly, the optimal timing for stopping insulin, whether at the first euglycaemic curve or after a sustained period of normal glucose, remains a matter of clinical judgment instead of evidence-based consensus. The ACVIM consensus statements provide a framework for monitoring but do not resolve these specific points ACVIM consensus statements.

Dietary carbohydrate restriction is widely endorsed, but the magnitude of benefit and the precise macronutrient targets remain contested. Reviews of feline carbohydrate metabolism acknowledge that the evolutionary argument for low-carbohydrate diets is plausible but that direct evidence linking carbohydrate content to remission outcomes is limited cats and carbohydrates, carnivore fantasy review.

Referral and Escalation Criteria

Referral to a specialist is warranted when remission is not achieved within three to four months of diagnosis despite appropriate insulin dosing, dietary compliance, and monitoring. Persistent insulin resistance, defined as a requirement above 1.5 U per kg per dose, should prompt investigation for acromegaly, hyperadrenocorticism, or other concurrent endocrinopathy. Cats with acromegaly may respond to radiotherapy with improved diabetic control, and this option should be discussed with an oncology or internal medicine service exogenous insulin after radiotherapy in cats with acromegaly.

Laboratory involvement is indicated when fructosamine results conflict with home glucose curves, when ketosis is suspected, or when concurrent disease such as pancreatitis or chronic kidney disease complicates management. Regulatory reporting is not typically required for feline diabetes, but clinicians should verify local requirements where controlled substances or unusual insulin products are involved.

Frequently Asked Questions

How Should I Adjust My Monitoring Plan When a Client Cannot Afford Frequent Glucose Curves or Continuous Glucose Monitors?

When cost limits monitoring, prioritize serial single blood glucose measurements taken 6 to 8 hours after insulin administration, combined with thorough owner observation of thirst, urination, appetite, and body condition. Spot checks at this interval capture the approximate nadir for most cats on twice-daily insulin protocols. Ask owners to record clinical signs daily and bring a urine glucose and ketone diary to each visit. Schedule in-hospital glucose curves at 7 to 14 day intervals during dose adjustments instead of weekly. If fructosamine is available, measure it every 3 to 4 weeks as a corroborating trend marker. The evidence base for monitoring frequency in remission induction remains moderate to poor, so adapt the interval to clinical stability and owner reliability Gostelow et al., systematic review of feline diabetic remission.

What Is the Minimum Equipment Set Needed to Manage Remission Induction Safely in General Practice?

A validated veterinary glucometer, an insulin syringe appropriate to the chosen insulin concentration, and a reliable scale are the minimum requirements. A urine glucose and ketone test strip adds value for home monitoring when blood sampling is difficult. Hospitalized patients need a laboratory or in-house analyzer capable of measuring blood glucose and fructosamine. Practices without continuous glucose monitoring can still achieve remission targets using serial blood glucose curves and owner observation. Long-acting insulin formulations administered twice daily remain the preferred initial choice in most cats Gottlieb and Rand, managing feline diabetes current perspectives. Confirm that the glucometer is calibrated for feline blood and that staff are trained in jugular, cephalic, and ear margin sampling techniques before starting a remission induction program.

How Do I Explain the Remission Concept and Monitoring Demands to an Owner Who Expects a Simple Cure?

Frame remission as a treatment goal, not a guaranteed outcome. Explain that early, consistent glycaemic control improves the chance of remission, and that remission means insulin independence while maintaining normal blood glucose. Emphasize that remission requires continued dietary discipline and periodic rechecks because relapse is possible. Show the owner the monitoring schedule in writing, including glucose curve dates, weight checks, and fructosamine sampling. Clarify that dose reductions are made only on the basis of recorded glucose data, not on clinical appearance alone. The systematic review of remission factors notes that study quality is moderate to poor, so avoid promising specific remission probabilities systematic review of feline diabetic remission. Set realistic expectations about the first 1 to 3 months of intensive monitoring.

What Should I Do When a Cat Achieves Remission but the Owner Cannot Maintain the Prescribed Low-Carbohydrate Diet?

Dietary consistency is a major determinant of sustained remission. If the owner cannot source or afford a commercial low-carbohydrate food, discuss home-prepared options with a veterinary nutritionist, or identify an alternative commercial product with the lowest carbohydrate content available locally. The evidence linking low-carbohydrate diets to higher remission rates is drawn from observational studies and expert opinion cats and carbohydrates, carnivore fantasy review. Advise the owner that any diet change should be gradual over 7 to 10 days and that glucose monitoring should be intensified during the transition. If the cat relapses, reinstate insulin promptly instead of waiting for clinical signs to become severe. Document the dietary compromise in the record and schedule a recheck sooner than the routine 3 month interval.

How Should I Record and Store Glucose Data to Support Later Dose Decisions?

Use a standardized form that captures date, time of insulin, time of each glucose measurement, insulin dose, food intake, and body weight. Record the glucose curve values in chronological order with the time since insulin administration noted for each reading. Store curves in the medical record as a dedicated diabetes flow sheet so trends are visible across visits. Ask owners to bring their home log to every appointment and transcribe key values into the record. Note any concurrent illness, medication changes, or diet deviations on the same form. Serial fructosamine values should be recorded alongside the curves to provide a longer-term trend. Consistent record keeping allows dose adjustments to be based on documented patterns instead of isolated readings ACVIM consensus statements on diagnosis and management.

When Should I Refer a Remission Candidate to a Specialist or Emergency Facility?

Refer when a cat fails to show any improvement in blood glucose after 2 to 4 weeks of appropriate insulin and dietary therapy, when insulin requirements exceed 1.5 units per kilogram per dose, or when recurrent hypoglycemia prevents dose escalation. Refer immediately for suspected acromegaly, hyperadrenocorticism, or other insulin-resistant states. Radiotherapy for acromegaly can improve diabetic control and may facilitate remission in selected cases, but this requires specialist imaging and treatment planning exogenous insulin treatment after hypofractionated radiotherapy in cats with acromegaly. Emergency referral is indicated for diabetic ketoacidosis, severe hypoglycemia with neurological signs, or suspected pancreatitis with systemic illness. Do not delay referral while attempting further empirical dose changes in a cat that is not responding as expected.

Related Clinical & Scientific Guides

• Feline Hepatic Lipidosis: Nutritional and Medical Management
• Canine Respiratory Infection: Diagnostic Approach and Treatment
• Canine Respiratory Virus: Diagnostic and Management Considerations

References and Further Reading

• Exogenous insulin treatment after hypofractionated radiotherapy in cats with diabetes mellitus and acromegaly.. 2009.
• Systematic review of feline diabetic remission: separating fact from opinion.. 2014.
• Cats and Carbohydrates: The Carnivore Fantasy?. 2017.
• Managing feline diabetes: current perspectives.. 2018.
• Feline comorbidities: Pathophysiology and management of the obese diabetic cat.. 2021.
• Diabetes mellitus in cats.. 2005.
• ACVIM Consensus Statements. Journal of Veterinary Internal Medicine.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Feline Hyperthyroidism: Treatment Selection and Monitoring Plan
• Canine Diabetes Mellitus: Insulin Therapy Adjustment Framework
• Feline Chronic Kidney Disease: Management and Monitoring Protocol
• Canine Hypoadrenocorticism: Diagnostic and Therapeutic Monitoring
• Feline Epilepsy: Diagnostic Approach and Treatment

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.